Aimed Alliance Shares Concerns Regarding Affordability Review Process with Oregon PDAB
Aimed Alliance submitted a comment to the Oregon Prescription Drug Affordability Board (PDAB) urging it…
Browsing: Federal
Aimed Alliance Sends Letter on CO AFP Legislation
Aimed Alliance sent a letter to Colorado Representative Ken DeGraaf’s regarding his special session bill …
FDA Warns Against Using Unapproved Blood Pressure Apps
On September 16, 2025, the Food and Drug Administration (FDA) issued a warning that many…
Aimed Alliance Publishes New PBM Reform Resource
Aimed Alliance has published a new resource highlighting pharmacy benefit manager (PBMs) practices and proposed…
HHS Launches Voluntary 340B Rebate Pilot for Negotiated Medicare Drugs
Following a May court ruling that pharmaceutical manufacturers must receive Health Resources and Services Administration…
CMS to Launch Pilot AI Model to Reduce Wasteful Medicare Spending
Beginning in January 2026, the Centers for Medicare & Medicaid Services (CMS) will launch the…
Aimed Alliance Urges Federal Action to Protect ACA Cost-Sharing and Drug Coverage Protections
On July 28, Aimed Alliance sent a letter to the Centers for Consumer Information and…
Aimed Alliance Urges MD PDAB to Conduct Patient-Centered, Evidence-Based Reviews
Prior to the Maryland Prescription Drug Affordability Board’s July meeting to conduct cost affordability reviews…
White House AI Plan May Limit State Authority on AI
On July 4, 2025, President Trump signed the One Big Beautiful Bill Act into law,…
New Report Highlights Gaps in Insurance and AI Consumer Protections
Washington, D.C. — June 30, 2025 — The not-for-profit Aimed Alliance, released a comprehensive new…